What Electra Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 36 | 36 |
| Sells | 0 | 0 |
| Total trades | 48 | 48 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 15,759,993 | 15,759,993 |
| Disposed | 0 | 0 |
| Net activity | +15,759,993 | +15,759,993 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gordon Carl L | Director | Nov 10 | Open-market buy · P | +2,000 | $8.45 | +$16.9K | 2,194,579 |
| Gordon Carl L | Director | Nov 10 | Open-market buy · P | +20,700 | $8.45 | +$175K | 5,255,278 |
| Orbimed Advisors Llc | Director | Nov 10 | Open-market buy · P | +2,000 | $8.45 | +$16.9K | 2,194,579 |
| Orbimed Advisors Llc | Director | Nov 10 | Open-market buy · P | +20,700 | $8.45 | +$175K | 5,255,278 |
| Gordon Carl L | Director | Nov 09 | Open-market buy · P | +16,000 | $8.24 | +$132K | 2,192,579 |
| Gordon Carl L | Director | Nov 09 | Open-market buy · P | +4,000 | $8.24 | +$33K | 5,234,578 |
| Orbimed Advisors Llc | Director | Nov 09 | Open-market buy · P | +16,000 | $8.24 | +$132K | 2,192,579 |
| Orbimed Advisors Llc | Director | Nov 09 | Open-market buy · P | +4,000 | $8.24 | +$33K | 5,234,578 |
| Gordon Carl L | Director | Nov 06 | Open-market buy · P | +39,600 | $7.85 | +$311K | 2,176,579 |
| Gordon Carl L | Director | Nov 06 | Open-market buy · P | +9,816 | $7.85 | +$77.1K | 5,230,578 |
| Orbimed Advisors Llc | Director | Nov 06 | Open-market buy · P | +39,600 | $7.85 | +$311K | 2,176,579 |
| Orbimed Advisors Llc | Director | Nov 06 | Open-market buy · P | +9,816 | $7.85 | +$77.1K | 5,230,578 |
| Gordon Carl L | Director | Nov 05 | Open-market buy · P | +125,200 | $7.31 | +$915K | 2,136,979 |
| Gordon Carl L | Director | Nov 05 | Open-market buy · P | +30,891 | $7.31 | +$226K | 5,220,762 |
| Orbimed Advisors Llc | Director | Nov 05 | Open-market buy · P | +125,200 | $7.31 | +$915K | 2,136,979 |
| Orbimed Advisors Llc | Director | Nov 05 | Open-market buy · P | +30,891 | $7.31 | +$226K | 5,220,762 |
| Gordon Carl L | Director | Nov 04 | Open-market buy · P | +20,000 | $7.07 | +$141K | 2,011,779 |
| Gordon Carl L | Director | Nov 04 | Open-market buy · P | +5,000 | $7.07 | +$35.4K | 5,189,871 |
| Gordon Carl L | Director | Nov 04 | Open-market buy · P | +37,100 | $7.78 | +$289K | 1,991,779 |
| Gordon Carl L | Director | Nov 04 | Open-market buy · P | +9,267 | $7.78 | +$72.1K | 5,184,871 |
Loading...